Literature DB >> 3918479

Anesthesia for hepatic transplantation: cardiovascular and metabolic alterations and their management.

F J Carmichael, M J Lindop, J V Farman.   

Abstract

We studied the cardiovascular and metabolic changes occurring during orthotopic liver transplantation in nine patients. The operative management of these patients can be divided into an initial dissection phase, an anhepatic phase when the hepatic artery, portal vein, and inferior vena cava are cross-clamped, and the phase after the release of these clamps. On clamping the inferior vena cava, the systolic arterial pressure decreased from 134 +/- 9 to 104 +/- 8 mm Hg, the pulmonary artery pressure decreased from 25 +/- 4 to 17 +/- 4 mm Hg, the mean pulmonary wedge pressure decreased from 11.9 +/- 1.9 to 6.8 +/- 1.2 mm Hg, and cardiac index decreased from 5.3 +/- 0.3 to 2.7 +/- 0.2 L X min-1 X m-2. There were compensatory increases in systemic vascular resistance from 806 +/- 52 to 1448 +/- 109 dyne X cm X sec-5 and in pulmonary vascular resistance from 78 +/- 13 to 122 +/- 25 dyne X cm X sec-5. Removal of these clamps was followed by an initial depression in cardiac output that returned to preclamping values. Profound metabolic alterations were encountered during these phases. Hydrogen ion concentration increased from a mean of 39 +/- 2 to 45 +/- 2 nmol/L during cross-clamping, with a further increase to 55 +/- 3 nmol/L after the initial perfusion of the new liver. Serum potassium levels increased significantly only on release of the clamps, from a mean of 3.8 +/- 0.3 to a peak of 5.3 +/- 0.6 mmol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918479

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  14 in total

1.  Anesthetic management for liver transplantation from living donor to adult recipient--a case report.

Authors:  N Sato; K Moriwaki; O Yuge; K Mukaida; M Kubota; M Sanuki
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

2.  Anaesthesia for organ transplantation.

Authors:  A W Gelb
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

3.  Glucose metabolism during liver transplantation in dogs.

Authors:  A M DeWolf; Y G Kang; S Todo; I Kam; A J Francavilla; L Polimeno; S Lynch; T E Starzl
Journal:  Anesth Analg       Date:  1987-01       Impact factor: 5.108

4.  Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases.

Authors:  E Delva; Y Camus; B Nordlinger; L Hannoun; R Parc; H Deriaz; A Lienhart; C Huguet
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

5.  Continuous monitoring of glucose levels in the hepatic vein and systemic circulation during the Pringle maneuver in beagles.

Authors:  Tomoaki Yatabe; Hiroyuki Kitagawa; Takashi Kawano; Masaya Munekage; Takehiro Okabayashi; Koichi Yamashita; Kazuhiro Hanazaki; Masataka Yokoyama
Journal:  J Artif Organs       Date:  2011-05-28       Impact factor: 1.731

6.  Extra-hepatic metabolism of midazolam.

Authors:  G R Park; A R Manara; S Dawling
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

7.  Oxygen consumption and mixed venous oxygen saturation monitoring during orthotopic liver transplantation.

Authors:  B D Spiess; K J Tuman; R J McCarthy; W G Logas; T R Lubenow; J Williams; H Sankray; P Foster
Journal:  J Clin Monit       Date:  1992-01

8.  Effect of flushing of the liver graft upon plasma calcium and magnesium concentrations.

Authors:  B H Pienaar; G Wilson; E Newman; J Fourie; H McLeod; M Bracher; Z Lotz; R Hickman
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

9.  Blood concentrations of dopexamine in patients during and after orthotopic liver transplantation.

Authors:  P A Gray; T Jones; G R Park
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

10.  Intraoperative hemodynamic modifications during pediatric orthotopic liver transplantation.

Authors:  M Carlier; L van Obbergh; F Veyckemans; J L Scholtes; J M Gouverneur; B F Gribomont; D Moulin; M Reynaert; B de Hemptinne; J B Otte
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.